Kailera Therapeutics
$2.07B
Developing injectable and oral obesity therapies
- $2.07B last priced transaction (as of 2026-04)
- 7 sourced signals across 1 data source
Loading the full interactive profile on VizierAtlas…
Developing injectable and oral obesity therapies
Loading the full interactive profile on VizierAtlas…